IMNM
Immunome Inc

2,227
Mkt Cap
$2.85B
Volume
2.08M
52W High
$26.36
52W Low
$5.15
PE Ratio
-8.75
IMNM Fundamentals
Price
$25.87
Prev Close
$25.82
Open
$25.63
50D MA
$20.27
Beta
1.36
Avg. Volume
2.85M
EPS (Annual)
-$5.00
P/B
8.99
Rev/Employee
$76,618.64
Loading...
Loading...
News
all
press releases
Immunome (NASDAQ:IMNM) Hits New 12-Month High - What's Next?
Immunome (NASDAQ:IMNM) Reaches New 1-Year High - Here's What Happened...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Immunome, Inc. $IMNM Holdings Boosted by Nisa Investment Advisors LLC
Nisa Investment Advisors LLC raised its stake in Immunome, Inc. (NASDAQ:IMNM - Free Report) by 3,513.0% in the third quarter, according to the company in its most recent disclosure with the...
MarketBeat·8d ago
News Placeholder
Immunome (NASDAQ:IMNM) Trading 8.1% Higher - Here's Why
Immunome (NASDAQ:IMNM) Trading Up 8.1% - Here's What Happened...
MarketBeat·8d ago
News Placeholder
Immunome (NASDAQ:IMNM) Receives Outperform Rating from Wedbush
Wedbush restated an "outperform" rating and issued a $31.00 price target on shares of Immunome in a research report on Thursday...
MarketBeat·9d ago
News Placeholder
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunome, Inc. (the Company) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on January 2, 2026, the...
Business Wire·15d ago
News Placeholder
Immunome to Present at 44th Annual J.P. Morgan Healthcare Conference
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at the...
Business Wire·18d ago
News Placeholder
Lightning Round: Nokia is up against a lot of tough companies, says Jim Cramer
'Mad Money' host Jim Cramer weighs in on stocks including: Voyager Technologies, Nokia, Immunome, and Dentsply...
CNBC Television-YouTube·18d ago
News Placeholder
Immunome (NASDAQ:IMNM) Shares Down 7% - Time to Sell?
Immunome (NASDAQ:IMNM) Stock Price Down 7% - Here's Why...
MarketBeat·18d ago
News Placeholder
Immunome, Inc. (NASDAQ:IMNM) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Immunome, Inc. (NASDAQ:IMNM - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eleven analysts that are presently covering the company, Marketbeat reports. One...
MarketBeat·19d ago
News Placeholder
Immunome (NASDAQ:IMNM) CEO Clay Siegall Purchases 4,729 Shares
Immunome, Inc. (NASDAQ:IMNM - Get Free Report) CEO Clay Siegall bought 4,729 shares of Immunome stock in a transaction dated Tuesday, December 30th. The stock was purchased at an average price of...
MarketBeat·24d ago
<
1
2
...
>

Latest IMNM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.